ICAD
Icad Inc
Halal Rating :
Last Price
$1.96
Last updated:
Market Cap
-
7D Change
2.62%
1 Year Change
28.95%
Company Overview
Industries
Exchange
Next Earnings Date
iCAD Inc. is a global medical technology company that provides innovative cancer detection and therapy solutions. The company develops, manufactures, and markets computer-aided detection and artificial intelligence solutions for the detection of cancer, primarily breast and prostate cancer. Their products include ProFound AI for Digital Breast Tomosynthesis (DBT) and PowerLook platforms for mammography and breast cancer detection.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $4.22m | $6.23m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $5.03m | $6.98m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $4.95m | $6.39m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Icad Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.